ASCL2 and colonic neoplasm: Together, our results establish HMGA1 as an epigenetic gatekeeper of ASCL2 and Wnt signals, inflammation, and a stem-like state in colon cells with APC inactivation, highlighting HMGA1 as a promising potential therapeutic target in colon cancer.